Study on immune cells and aging blood vessels pulled before start
NCT ID NCT04344873
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to see if certain immune cells (T cells) contribute to age-related blood vessel problems that raise heart disease risk. It planned to give a single injection of abatacept to adults aged 55-75 and measure changes in artery function and inflammation. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your heart hold the key to Alzheimer's prevention?
- Can better healthcare access save hearts after prison?
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Could a simple health chat slash heart disease and cancer risk?
- Could a stress hormone be behind the hidden danger of low blood sugar?